RightFit
RecruitingNot applicable

HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction

HEART (Heart Failure Exercise and Resistance Training) Camp Connect: Promoting Adherence to Exercise in Adults With Heart Failure With Preserved Ejection Fraction

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Mentioned in the study description

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 18 months, 7 days
  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will be randomly placed in one of three groups for 18 months."
  • "At four data collection time points, participants will wear an activity monitor for 7 days each, have their blood drawn, and answer questions related to heart failure and exercise."
  • "At these data collection time points, participants will also wear an activity monitor for 7 days/nights and complete surveys related to their heart failure and exercise."
Compensation
Mentioned in the study description
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study is for adults with heart failure whose hearts still pump out a normal share of blood, called HFpEF. It tests whether exercise coaching in person or by video helps them exercise, feel better, and change markers measured in their blood. Participants are placed by chance into one of three groups for 18 months, including a group without a coach.

The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Participants will be randomly placed in one of three groups for 18 months. All groups will have access to a fitness center and be given a watch and heart rate monitor to wear during exercise. The usual care group (control group) will have access to exercise videos via the medical fitness center and will not meet with a coach. The HEART Camp group will exercise and meet with their coach in-person at the medical fitness center. The HEART Camp Connect group will have access to exercise videos via the medical fitness center and will meet with their coach via videoconferencing. All participants will take part in an exercise test and study training prior to being randomized. At four data collection time points, participants will wear an activity monitor for 7 days each, have their blood drawn, and answer questions related to heart failure and exercise. Participants will also wear a heart rate monitor when they exercise and fill out a daily exercise diary.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have heart failure with an ejection fraction of at least 50%, meaning the heart pumps out at least half the blood it holds with each beat.
  • Have had an echocardiogram, an ultrasound of the heart, in the past 24 months.
  • Have been on stable medicine treatment for the past 30 days.
  • Have evidence of HFpEF: a score below 6 on the study’s heart failure scoring tool, pressure measurements taken inside the body that show HFpEF, or a confirmed diagnosis from a clinician.

Who can't join

  • Have an illness that limits life enough to prevent finishing the study.
  • Have signs that heart failure is getting worse.
  • Have unstable chest pain from low blood flow to the heart, or severe shortness of breath with very light activity.
  • Had a heart attack, heart bypass surgery, or placement of a pacemaker for both lower heart chambers in the past 6 weeks.
  • Have bone, joint, muscle, or nerve problems that prevent aerobic exercise, or exercise test results showing exercise is unsafe.
  • Are unwilling or unable to finish the required tests and training before being assigned to a group.
  • Are pregnant.
  • Have an implanted defibrillator, a device that shocks the heart to correct dangerous rhythms.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosis of heart failure with an ejection fraction greater than or equal to 50 * Echocardiogram in prior 24 months * Stable pharmacologic therapy in the past 30 days * Any of the following evidence to confirm HFpEF - Score\< 6 on Heavy Hypertensive Atrial Fibrillation, Pulmonary Hypertension, Elder, Filling Pressure algorithm, invasive hemodynamic evidence of HFpEF(i.e., elevated pulmonary wedge pressure), or a confirmed clinical diagnosis of HFpEF Exclusion Criteria: * Life-limiting illness precluding study completion * Clinical evidence of decompensated heart failure * Unstable angina or marked shortness of breath on exertion at less than 2 metabolic equivalents * Myocardial infarction, coronary artery bypass graft, or biventricular pacemaker in prior 6 weeks * Orthopedic or neuromuscular disorders preventing aerobic exercise * Cardiopulmonary exercise test results that preclude safe exercise * Unwilling/unable to complete pre-randomization procedures * Pregnancy * Implantable cardioverter defibrillator

Study sites (3)

MI

NE

VA